Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials

UNC Libraries(2024)10.17615/79qz-k873Source: DataRank Database

Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials is a research paper published in UNC Libraries (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: greenTopics (31)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Srinivas Murthy ORCID,Katie E Webster ORCID,Richard Haynes ORCID,Martin Landray ORCID,Godolphin P.J

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W4403085424

National Institutes of Health

Grant: 3OT2HL156812-01SD

ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating Center

UK Research and Innovation

Grant: MC_UU_00004/06

Method Meta-analysis

UK Research and Innovation

Grant: MC_PC_19056

COVID-19: multi-arm, multi stage adaptive clinical trial (CoV-MAMS)

Wellcome Trust

Grant: 222406

RECOVERY (Randomised Evaluation of COVID-19 Therapy) International

FWCI

0.00

Citation Percentile

0.1%

greenLicense: CC BY

repositoryhttps://doi.org/10.17615/79qz-k873

https://doi.org/10.1016/s2213-8587(24)00219-5

https://dx.doi.org/10.17615/79qz-k873

https://pubmed.ncbi.nlm.nih.gov/39250923

https://ora.ox.ac.uk/objects/uuid:1aff6b8b-2467-4e9b-956e-d8c870440169

Fields of Study

Diabetes Treatment and ManagementNeuroendocrine Tumor Research AdvancesPancreatitis Pathology and Treatment03 medical and health sciences0302 clinical medicine

Keywords

Coronavirus disease 2019 (COVID-19)Meta-analysisMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)TransporterInternal medicineRandomized controlled trialPharmacologyVirologyChemistryBiochemistryDiseaseMaleSARS-CoV-2610COVID-19COVID-19 Drug TreatmentHospitalizationTreatment OutcomeDiabetes Mellitus, Type 2HumansFemaleProspective StudiesSodium-Glucose Transporter 2 InhibitorsRandomized Controlled Trials as Topic